Search

Search Constraints

You searched for: Author/Creator Ogawa, Yuji

Search Results

1. Accuracy of the Enhanced Liver Fibrosis test, and combination of the Enhanced Liver Fibrosis and non‐invasive tests for the diagnosis of advanced liver fibrosis in patients with non‐alcoholic fatty liver disease. Issue 6 (25th March 2020)

2. An outbreak of Paragonimus westermani infection among Cambodian technical intern trainees in Japan, exhibiting various extrapulmonary lesions. (April 2021)

3. Assessment of 10‐year changes in liver stiffness using vibration‐controlled transient elastography in non‐alcoholic fatty liver disease. Issue 8 (23rd May 2019)

4. Assessment of suitable antihypertensive therapies: Combination with high‐dose amlodipine/irbesartan vs triple combination with amlodipine/irbesartan/indapamide (ASAHI‐AI study). Issue 9 (6th August 2020)

5. Association of Serum and Fecal Bile Acid Patterns With Liver Fibrosis in Biopsy-Proven Nonalcoholic Fatty Liver Disease: An Observational Study. Issue 7 (26th July 2022)

6. Autotaxin is a valuable biomarker for the prediction of liver fibrosis in patients with non‐alcoholic fatty liver disease. Issue 10 (4th July 2019)

7. Characteristics of non‐obese non‐alcoholic fatty liver disease: Effect of genetic and environmental factors. Issue 10 (5th April 2016)

8. Combination of tofogliflozin and pioglitazone for NAFLD: Extension to the ToPiND randomized controlled trial. Issue 9 (16th May 2022)

9. Comparing the effects of tofogliflozin and pioglitazone in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus (ToPiND study): a randomized prospective open-label controlled trial. Issue 1 (16th February 2021)

10. Comparison of long‐term prognosis between non‐obese and obese patients with non‐alcoholic fatty liver disease. Issue 10 (24th August 2022)